The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?

Iván Peñuelas; Daniëlle J. Vugts; Clemens Decristoforo; Philip H. Elsinga

doi:10.1186/s41181-019-0055-6

The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?

Iván Peñuelas^*
, Daniëlle J. Vugts
, Clemens Decristoforo
, Philip H. Elsinga

^*Corresponding author for this work

University of Navarra
Innsbruck Medical University
University of Groningen

Research output: Contribution to journal › Editorial › Academic › peer-review

11 Downloads (Pure)

Original language	English
Article number	2
Journal	EJNMMI Radiopharmacy and Chemistry
Volume	4
Issue number	1
DOIs	https://doi.org/10.1186/s41181-019-0055-6 https://doi.org/10.1186/s41181-019-0055-6
Publication status	Published - 1 Dec 2019

Access to Document

The-new-regulation-on-clinical-trials-in-relation-to-radiopharmaceuticals-when-and-how-will-it-be-implemented.pdfFinal published version, 451 KBLicence: Taverne

Cite this

@article{7dc17d2d270d4b788decc9ae70d04d2d,

title = "The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?",

author = "Iv{\'a}n Pe{\~n}uelas and Vugts, \{Dani{\"e}lle J.\} and Clemens Decristoforo and Elsinga, \{Philip H.\}",

year = "2019",

month = dec,

day = "1",

doi = "10.1186/s41181-019-0055-6",

language = "English",

volume = "4",

journal = "EJNMMI Radiopharmacy and Chemistry",

issn = "2365-421X",